Skip to content
UPDATE: Section 122 tariff (10%) in effect since Feb 24 — expires ~July 24 (~126 days). 24 states challenge in court (March 5). USTR launches new Section 301 probes (March 11). EU trade deal vote imminent. Full analysis →
Tariffs Tool
🇮🇪

US Tariffs on Imports from Ireland

Updated 2026-03-20
Updated Feb 21, 2026: IEEPA tariff (was 20%) struck down by SCOTUS Feb 20. Replaced by 10% Section 122 tariff (effective Feb 24, expires ~July 24). Rate decreased from 20% to 10%. Section 122 tariffs expire ~July 24, 2026.
Section 122 Tariff
10%
was 20% (IEEPA)
232 Steel
50%
232 Aluminum
50%
Rate dropped from 20% (IEEPA) to 10% (Section 122). EU member. Major pharma/tech exporter.

Ireland Import Tariff Overview

Ireland now faces a 10% Section 122 tariff (effective Feb 24, 2026), down from 20% under the struck-down IEEPA regime. Despite the headline rate, Ireland's ~$75B in annual US imports are heavily concentrated in pharmaceuticals (0% MFN) and technology products — making it one of the largest per-capita exporters to the US. Pfizer, Apple, and other US multinationals operating in Ireland drive the trade profile.

Ireland is a major hub for US pharmaceutical and technology companies, with Pfizer, Johnson & Johnson, Eli Lilly, Apple, Google, and Intel operating significant manufacturing and services operations there. The large trade surplus with the US is substantially driven by transfer pricing and intellectual property flows — Ireland's headline trade figures significantly overstate the value of physical goods production. Ireland's 12.5% corporate tax rate (now 15% under OECD Pillar Two for large multinationals) has attracted enormous US foreign direct investment, creating a unique bilateral trade dynamic where many of the largest 'Irish' exporters are actually US companies.

Key Products Imported from Ireland

Top imports include pharmaceuticals and medical devices (the largest category by far, including biologics from Pfizer, Eli Lilly, and Amgen), organic chemicals, optical and medical instruments, computer equipment, and food products (dairy, beef, Irish whiskey). Ireland's pharmaceutical exports alone account for a majority of the bilateral goods trade.

Recent Changes

Feb 20, 2026: SCOTUS struck down IEEPA tariffs 6-3 — Ireland's rate dropped from 20% to 10% under Section 122 (effective Feb 24, expires ~July 24, 2026). Section 232 steel and aluminum tariffs of 50% remain. Ireland's pharmaceutical manufacturing continues to expand, with new biologics facilities from Pfizer, Eli Lilly, and Amgen. OECD Pillar Two global minimum tax (15%) is being implemented, which may affect the transfer pricing dynamics that inflate Ireland's trade surplus. Irish whiskey exports are growing rapidly, now the world's fastest-growing spirits category. EU retaliatory measures on US goods apply.

Tips for Importers

Pharmaceuticals and most medical devices enter at 0% MFN duty, so the 10% Section 122 tariff is the only layer — and it just dropped by 10 points. For biologics and specialty drugs worth billions annually, this reduction represents massive savings. Many 'Irish' exports are products of US companies (Pfizer, Apple, Intel) manufactured in Ireland — verify whether domestic US sourcing alternatives exist to avoid the tariff entirely. For organic chemicals, most HTS codes carry 0% MFN rates. Irish whiskey faces 10% Section 122 plus specific MFN spirits duties (~$13.50 per proof gallon) — compare with Scotch whisky (same rate) and bourbon (no tariff as domestic). Transfer pricing means the declared customs value of Irish pharmaceutical exports may be scrutinized by CBP. The Section 122 tariff expires ~July 24, 2026 — plan accordingly.

Rates by Product Sector

SectorBase RateSurchargeEffective RateNotes
Electronics0%Free
Clothing & Apparel16.5%16.5%
Automobiles & Parts2.5%2.5%
Steel & Aluminum0%+50%50%Section 232 50% (doubled June 2025)
Food & Agriculture5%5%
Machinery & Equipment2.5%2.5%
Pharmaceuticals0%Free100% on patented pharma

Calculate Duty from Ireland

Tariff rates change fast. Stay ahead.

Free alerts when US import tariff rates change. Join importers and trade professionals who stay informed.

No spam. Unsubscribe anytime.

Frequently Asked Questions

How does the tariff reduction affect Pfizer and other pharmaceutical imports from Ireland?
Irish pharmaceuticals enter at 0% MFN duty, making the Section 122 tariff the only cost layer — now 10% instead of 20% IEEPA. For a $1B biologics shipment, the 10-point reduction saves approximately $100M in tariffs. However, many pharmaceutical companies manufacturing in Ireland are US-headquartered (Pfizer, Eli Lilly, Amgen), and the declared customs values of these imports may reflect transfer pricing dynamics that CBP increasingly scrutinizes.
Why does Ireland export so much to the US despite its small size?
Ireland's trade figures are substantially inflated by transfer pricing and intellectual property flows. US multinationals (Apple, Google, Pfizer) route significant revenue and IP through Irish subsidiaries, creating headline trade figures that overstate the physical goods actually produced there. Under OECD Pillar Two (15% global minimum tax), some of these dynamics may shift, but Ireland remains a genuine pharmaceutical manufacturing hub with world-class biologics facilities.
Is Irish whiskey competitive versus Scotch whisky in the US market?
Both now face identical tariff treatment: 10% Section 122 plus specific MFN spirits duties. Irish whiskey is the world's fastest-growing spirits category and has been gaining US market share. The level tariff playing field means competition is based on brand positioning, taste preferences, and marketing rather than tariff differentials. Both remain disadvantaged versus USMCA-qualifying spirits from Mexico and Canada.
How does OECD Pillar Two affect Ireland's trade with the US?
Ireland's 12.5% corporate tax rate (now effectively 15% for large multinationals under Pillar Two) was a key driver of US companies locating production and IP in Ireland. As Pillar Two reduces the tax incentive, some companies may reshore production to the US or diversify manufacturing locations. This could gradually shift Ireland's trade profile, though existing pharmaceutical and technology facilities represent long-term investments unlikely to relocate quickly.

Related Countries

Related Product Categories

Popular Tariff Lookups